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Abstract: The objective of this study was to investigate the effect of IV injection of oxytocin (OT) on serum and seminal plasma
levels of oestradiol (E2), testosterone (T), dehydroepiandrosterone sulphate (DHEA-S), and semen characteristics in rams. Twelve
3-year-old Awassi adult rams were randomly divided into 2 equal groups (control and treatment). Physiological saline (0.5 ml) was
injected IV into each ram in the control group, whereas OT was administered IV at a single dose of 5 IU to each ram in the treatment
group. Blood samples were collected from the jugular vein and semen samples were taken by an electroejaculator from all rams
sequentially at 10, 60, and 120 min after the IV injection of physiological saline or OT. Administration of OT had no effect on blood
or seminal plasma E2 or DHEA-S levels, or on serum T at any collection time compared to the control group. However, while OT
increased significantly the level of seminal plasma T at 10 min, its effect was absent at 60 and 120 min after the injection compared
to the control group. OT did not alter the semen viscosity, sperm motility, or abnormal sperm rate at all times in comparison to the
control values. Although semen volume, mass activity, sperm concentration, total sperm number, and total motile sperm number of
the treatment group increased significantly at 10 min compared to the control group, all these parameters decreased markedly at
60 and 120 min in comparison with 10 min after injection in both the control and treatment groups. In conclusion, exogenous OT
increases seminal plasma T, semen volume, mass activity, sperm concentration, total sperm number, and total motile sperm number
in the first ejaculate of the rams 10 min after the IV administration.
Key Words: Oxytocin, oestradiol, testosterone, dehydroepiandrosterone sulphate, semen characteristics, ram

Egzojen Uygulanan Oksitosinin Koçlarda Serolojik ve Seminal Steroidler ile
Spermatolojik Özellikler Üzerine Etkileri
Özet: Bu çal›ﬂma damar içi oksitosin (OT) enjeksiyonunun koçlarda serum ve seminal plazma östradiol (E2), testosteron (T),
dehidroepiandrosteron sülfat (DHEA-S) düzeyleri ve spermatolojik özellikler üzerine etkilerini araﬂt›rmak amac›yla yap›lm›ﬂt›r.
Çal›ﬂmada 3 yaﬂlar›nda 12 yetiﬂkin ‹vesi koçu kullan›ld› ve her bir grupta 6 koç olacak ﬂekilde kontrol ve uygulama grubu olmak
üzere rasgele iki gruba ayr›ld›. Kontrol grubundaki her bir koça 0.5 ml fizyolojik tuzlu su damar içi verilirken uygulama
grubundakilere ise 5 IU OT uyguland›. Fizyolojik tuzlu su ya da OT uygulamas›ndan sonraki 10, 60 ve 120. dakikalarda V.
jugularisten kan ve elektroejakülatör yard›m›yla da sperma örnekleri topland›. Kontrol grubu ile karﬂ›laﬂt›r›ld›¤›nda, OT uygulamas›
serum ve seminal plazma E2 ve DHEA-S düzeyleri ile serum T miktar›n› tüm zamanlarda etkilemedi. Bununla birlikte OT kontrol
grubu ile karﬂ›laﬂt›r›ld›¤›nda 10. dakikadaki seminal plazma T düzeyini önemli derecede art›r›rken 60 ve 120. dakikalarda ise etkisiz
kald›. Kontrol grubuyla karﬂ›laﬂt›r›ld›¤›nda tüm zamanlarda, OT sperman›n ak›ﬂkanl›¤›n›, motilitesini ve anormal spermatozoon
oran›n› de¤iﬂtirmedi. Uygulama grubunun sperma miktar›, kitle hareketi, spermatozoon yo¤unlu¤u, toplam spermatozoon say›s› ve
toplam motil spermatozoon say›s› kontrol grubuna göre 10. dakikada önemli derecede artmas›na ra¤men, tüm bu parametreler 10.
dakika ile karﬂ›laﬂt›r›ld›¤›nda 60 ve 120. dakikalarda hem kontrol ve hem de uygulama grubunda önemli derecede azald›. Sonuç
olarak koçlara damar içi OT uygulamas› 10. dakikada al›nan ilk ejakülattaki seminal plazma T, sperma miktar›, kitle hareketi,
spermatozoon yo¤unlu¤u, toplam spermatozoon say›s› ve toplam motil spermatozoon say›s›n› art›rmaktad›r.
Anahtar Sözcükler: Oksitosin, östradiol, testosteron, dehidroepiandrosteron sülfat, spermatolojik özellikler, koç

Introduction
Oxytocin (OT) is a naturally occurring hormone in the
female and male organism of all mammalian species. Its

chemical structure is a nonapeptide. Endogenous OT is
produced in the nucleus supraopticus and the nucleus
paraventricularis of the hypothalamus. By neurosecretion
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the hormone migrates to the posterior lobe of the
hypophysis, where it is stored, and it is released in
response to nervous stimuli (1).
OT has specific effects on contraction of smooth
muscle of uterus and cells of mammary gland in the
females, but the physiological function of OT in the male
is unclear. However, it has been reported that OT
advances the sperm movement during its transport from
ductuli efferentes and epididymis (2) by stimulating
smooth muscle cells. This function of OT is supported by
the localisation of the OT receptors in the epididymis (3),
ductus deferens (4), and the presence of receptors on
intratubular regions (5), Leydig, and Sertoli cells (6). OT
is also produced locally by Leydig cells (7,8) and made in
a particular place of the testis, and in the epididymis and
prostate (9). During sexual stimulation and ejaculation,
OT is released from the neurohypophysis into the
peripheral circulation (10). Furthermore, OT
administration facilitates semen collection by
electroejaculation (11). It has been reported that OT
injection before the semen collection increases sperm
concentration in several mammalian species such as rams
(12), rabbits (13), bulls (14), and buffalos (15).
Testosterone (T), which is secreted from Leydig cells
in the testes, regulates the development, growth, and
maintenance of secondary sex characteristics in males
(16). Some researchers (5,17) have reported that OT
treatment reduces the T concentration whereas others
(8,18) have reported that this hormone increases the
release of T and some (19,20) have documented that OT
injection does not alter the concentration of T.
Dehydroepiandrosterone (DHEA) is formed
predominantly in the zona reticularis of the adrenal gland
(21) and a little in Leydig cells (22), and is reversibly
converted to dehydroepiandrosterone sulphate (DHEA-S),
which is the most abundant circulating hormone in
mammals (21). Both DHEA and DHEA-S are
prohormones without known receptors or specific target
tissues. The adrenal androgens have minimal androgenic
activity, and they contribute to androgenic function by
converting intracellular androgens to bioactive androgens
and oestrogens (23). Chiodera and Coiro (24) have
reported that OT administration reduces the plasma
DHEA-S level.
Oestrogens are necessary not only for female
reproduction but also for male reproduction. Oestrogens
together with androgens have an essential role in the
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differentiation and functional activity of the epididymis
(25,26). Oestrogens are present in the seminal plasma
and a substantial source of them is the secretory activity
of prostate. This study was conducted to investigate the
effect of OT on semen characteristics and levels of E2, T,
and DHEA-S in serum and seminal plasma of rams.
Materials and Methods
Animals and location
Twelve 3-year-old Awassi adult healthy rams were
used in the present study. The rams, raised at the Centre
of Education, Research and Application at the Faculty of
Veterinary Medicine, University of F›rat, were used
during the breeding season (September) and were kept
under natural climate conditions in Elaz›¤ province,
located at the latitude of 38°40'N. The animals were fed
on grass supplemented with lucerne hay and fresh
drinking water was provided ad libitum. The rams were
randomly divided into 2 equal groups: control and
treatment.

Sample collection and OT administration
Physiological saline (0.5 ml, 0.9% NaCl) was injected
IV into each ram in the control group whereas OT was
administered IV at a single dose of 5 IU (Oxytocin 10
IU/ml, Vetaﬂ, ‹stanbul, Turkey) to each ram in the
treatment group. Blood samples were collected from the
jugular vein and semen samples were taken by an
electroejaculator from all rams sequentially at 10, 60,
and 120 min after IV injection of physiological saline or
OT. This single dose of OT is recommended for the
contractility of smooth muscles in sheep. Blood and
semen samples were centrifuged at 3000 ×g for 5 min;
the serum and seminal plasma were separated and stored
at -20 °C until assayed. Serum and seminal plasma E2, T,
DHEA- S, and semen characteristics of all rams were
determined.

Measurement of steroids
The serum and seminal plasma E2 levels were
measured by Double-Antibody RIA using a DSL – 4400 kit
(Diagnostic System Laboratories Inc. Texas, USA) in a
gamma counter (LKB-Wallac Multigamma) according to
the manufacturer’s instructions. The calibration range
and sensitivity of the E2 kit were 20 to 6000 and 4.7
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pg/ml, respectively. The intra- and inter-assay variation
coefficients of the kit were 3.2% to 5.3% and 8.1% to
9.3%, respectively.
The serum and seminal plasma T and DHEA-S levels
were measured by Coated-Tube RIA using ActiveTM DSL4000 for T and ActiveTM DSL-3500 for DHEA-S in a
gamma counter according to the manufacturer’s
instructions. The calibration ranges of the T and DHEA-S
kits were 0.1 to 25 ng/ml and 5 to 800 µg/dl,
respectively. The sensitivity of the T and DHEA-S kits
were 0.08 ng/ml and 1.7 µg/dl, respectively. The intraassay variation coefficients of the T and DHEA-S kits were
7.8% to 9.6% and 6.3% to 9.4%, respectively. The
inter-assay variation coefficients of the T and DHEA-S kits
were 8.4% to 9.1% and 9.6% to 10.0%, respectively.

The total motile sperm number was also calculated by
multiplying the total sperm number by the percentage of
sperm motility.

Data analyses
The data are presented as mean ± standard error of
the mean (SEM). The level of significance was set at P <
0.05. Non-parametric Mann Whitney-U test was used to
determine the differences between the control and
treatment groups. To determine the differences among
time divisions, 2-way analysis of variance for repeated
measures were used. All data were analysed by SPSS/PC
(Version 10.0; SPSS, Chicago, IL, USA).

Results
Semen evaluation
Semen volume was determined by direct reading of
the graduations on the collection tube (from 0.1 to 10
ml). Semen viscosity was established visually with a scale
of 0-5 (from watery to creamy). To determine the mass
activity, a non-coverslipped drop of non-diluted fresh
semen was placed on a warm slide (37 °C) under a light
microscope with heated stage at 100× magnification. The
condenser diaphragm of the microscope was lowered in
order to increase the contrast. The following descriptors
were used for mass activity: 5: rapid dark swirls; 4:
slower dark swirls and eddies; 3: little slower swirls; 2:
no swirls, but prominent individual cell motion; 1: little
individual cell motion; and 0: no individual cell motion (1).
Semen samples were diluted with isotonic sodium
citrate solution at 37 °C (3%, w/v dissolved in distilled
water) at the rate of 1:10 (semen to sodium citrate). A
slide was placed on the light microscope and warmed up
to 37 °C. A small droplet of diluted semen was placed on
the slide and the percent motility was evaluated visually at
a magnification of 400×. Motility estimations were
performed from 3 different fields in each sample. The
mean of the 3 estimations was used as the final motility
score. The percentage of morphologically abnormal
spermatozoa was determined from the slides prepared
with Indian ink. A total of 300 spermatozoa were
counted on each slide under the light microscope at 400×
magnification. Sperm concentration was measured with a
haemocytometer (1).
The total sperm number was calculated by multiplying
the semen volume by the number of sperm per millilitre.

The serum E2, T, and DHEA-S levels of the rams are
given in Table 1. No significant differences were observed
between the control and treatment groups, or among
time divisions.
The seminal plasma E2, T, and DHEA-S levels are
presented in Figures 1-3, respectively. The administration
of OT did not affect E2 or DHEA-S levels at any time
compared to the control group. However, while OT
administration significantly increased (P < 0.05) the level
of seminal plasma T at 10 min, its effect was absent at
60 and 120 min after the injection compared to the
control group.
The values regarding the semen characteristics are
given in Table 2. It was observed that OT administration
did not alter the semen viscosity, sperm motility, or
abnormal sperm rate at any time in comparison with the
control group. Although semen volume, mass activity,
sperm concentration, total sperm number, and total
motile sperm number of the treatment group increased
significantly (P < 0.05) at 10 min after the injection of
OT compared to the control group, all these parameters
decreased markedly (P < 0.01) at 60 and 120 min after
the injection in comparison with 10 min in both the
control and treatment groups.

Discussion
Synthetic OT is structurally identical to the naturally
occurring hormone. OT and its synthetic analogue have
been used for a long time in human and veterinary
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Table 1. The mean serum oestradiol (E2), testosterone (T), and dehydroepiandrosterone sulphate (DHEA-S) levels of control and treatment groups
at all times.
Time
10 min

60 min

120 min

Oestradiol
(pg/ml)

Control
Treatment

24.14 ± 0.86
21.08 ± 1.07

29.94 ± 0.51
28.84 ± 0.67

26.52 ± 1.08
30.42 ± 1.90

Testosterone
(ng/ml)

Control
Treatment

3.78 ± 1.07
5.37 ± 1.12

4.13 ± 0.96
3.40 ± 1.04

4.74 ± 0.68
3.88 ± 0.52

Dehydroepiandrosterone
sulphate (µg/dl)

Control
Treatment

13.55 ± 1.21
14.15 ± 1.96

11.94 ± 2.85
13.80 ± 1.50

14.28 ± 2.06
12.75 ± 0.79

50
45
40
35
30
25
20
15
10
5
0

Control

10 min

Treatment

60 min

Dehydroepiandrosterone Sulphate
(µg/dl)

Oestradiol (pg/ml)

Data are expressed as mean ± SEM.
No significant differences were observed between the control and treatment groups, or among time divisions.

120 min

Figure 1. The mean seminal plasma oestradiol (E2) levels of the
control and the treatment groups at all times.
No significant differences were observed between the control
and the treatment groups, or among time divisions.

Control

Testosterone (ng/ml)

1.4
1.2

Treatment

a*

1
b

0.8

b

0.6
0.4
0.2
0

10 min

60 min

120 min

Figure 2. The mean seminal plasma testosterone (T) levels of the
control and the treatment groups at all times.
(*): P < 0.05, vs. control.
(a, b): Different letters show significant differences (P <
0.01) among time divisions.
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Control

Treatment

10
8
6
4
2
0
10 min

60 min

120 min

Figure 3. The mean seminal plasma dehydroepiandrosterone sulphate
(DHEA-S) levels of the control and the treatment groups at
all times.
No significant differences were observed between the control
and the treatment groups, or among time divisions.

medicine. Therefore, many studies have been conducted
on the relationship between OT and other hormones.
However, the data pertaining to the effect of OT on T are
controversial, because some researchers (5) have
reported that OT treatment reduces the T concentration
whereas others (8) have reported that this hormone
increases the release of T, and some (19) have also
documented that OT does not alter the concentration of
T. In the present study it was observed that the
administration of OT did not affect the levels of serum T
at any time compared to the control group. However, OT
administration increased significantly the level of seminal
plasma T at 10 min, but its effect was absent at 60 and
120 min compared to the control group. This increase in
seminal plasma T of the treatment group at 10 min after
the injection may be due to the elevation of testosterone
level in prostatic fluid by OT administration. This
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Table 2. The mean values pertaining to the semen characteristics of the control and treatment rams at all times.
Semen
characteristics

Time
10 min

60 min

120 min

Volume
(ml)

Control
Treatment

0.93 ± 0.11
1.26 ± 0.15a*

a

0.70 ± 0.08b
0.75 ± 0.19b

0.30 ± 0.02c
0.35 ± 0.05c

Viscosity
(0-5)

Control
Treatment

3.69 ± 0.16
3.94 ± 0.06

3.82 ± 0.24
3.50 ± 0.16

3.45 ± 0.14
3.50 ± 0.12

Mass activity
(0-5)

Control
Treatment

4.00 ± 0.19a
4.50 ± 0.19a*

3.08 ± 0.05b
3.43 ± 0.28b

2.99 ± 0.09b
3.10 ± 0.18b

Sperm motility
(%)

Control
Treatment

80.63 ± 3.33
86.25 ± 1.83

77.52 ± 3.21
81.88 ± 1.32

75.16 ± 2.37
78.13 ± 1.88

Sperm concentration
(×109/ml)

Control
Treatment

2.93 ± 0.22
3.56 ± 0.16a*

a

2.06 ± 0.16b
2.36 ± 0.21b

1.89 ± 0.10b
2.08 ± 0.12b

Total sperm
number (×109)

Control
Treatment

2.72 ± 0.42a
4.48 ± 0.61a*

1.44 ± 0.28b
1.77 ± 0.69b

0.56 ± 0.09c
0.73 ± 0.16c

Total motile sperm
number (×109)

Control
Treatment

2.19 ± 0.27a
3.86 ± 0.32a*

1.11 ± 0.08b
1.44 ± 0.15b

0.42 ± 0.08c
0.57 ± 0.05c

Abnormal sperm
rate (%)

Control
Treatment

9.88 ± 1.38
8.83 ± 1.33

10.54 ± 2.35
11.63 ± 1.81

12.46 ± 2.04
11.70 ± 1.30

Data are expressed as mean ± SEM.
(*): P < 0.05, vs. control
a, b, c
( ) Different letters within the same row show significant differences (P < 0.01) among time divisions.

hypothesis is supported by Nicholson and Jenkin (27),
who reported that OT treatment increases the
testosterone level in prostate tissue. Furthermore, the
decrease in the levels of seminal plasma T at 60 and 120
min may be elucidated with the short half-life of OT
(approximately 22 min) in small ruminants (28).
DHEA and DHEA-S are distal precursors of oestrogen
formation (21). It has been reported (29) that the
administration of DHEA or its metabolite causes a
significant increase in mean E2 levels. Chiodera and Coiro
(24) suggested that IV administration of OT decreases the
plasma DHEA-S in humans. OT did not affect the level of
serum or seminal plasma DHEA-S at any time compared
to the control values in the present study. The difference
between our results and those reported by Chiodera and
Coiro (24) may be due to the use of different materials
and dose. The lack of the effect of OT on DHEA-S may be

attributed to the possibility that OT has no significant
effect on the adrenal gland, where it is predominantly
produced.
Oestrogens and androgens have an essential role in
the differentiation and functional activity of the
epididymis (25,26). The effect of OT on corpus
cavernosum (30) and epididymal contractility (31) is
regulated by oestrogens. Berndtson et al. (32) reported
that OT inhibits E2 production in bovine granulosa cells
without affecting the aromatase activity. There are no
available data on the effect of OT on E2 levels in rams.
The results of this study showed that OT did not alter
either serum or seminal plasma E2 levels. Although the
aromatase activity was not measured in the present
study, this situation may be explained by the fact that OT
has no effect on aromatase activity, which converts
androgens to oestrogens.
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During sexual stimulation and ejaculation, OT is
released from the neurohypophysis into the peripheral
circulation (10). Furthermore, OT administration
facilitates the semen collection by electroejaculation (11)
and causes an increase in the sperm concentration in rams
(12), bulls (14), and buffalos (15). Fuchs et al. (33)
found that in vitro addition of OT to semen significantly
increased the percentage of motile spermatozoa in bulls;
whereas Sliwa (34) suggested that intratesticular
administration of OT decreased the sperm motility in
mice. Walch et al. (35) reported that OT has no
detectable effect on ejaculation time and seminal
parameters after intranasal application in normal, healthy
men. This study showed that OT did not alter the semen
viscosity, sperm motility, or abnormal sperm rate at any
time in comparison with the control group. Although
semen volume, mass activity, sperm concentration, total
sperm number, and total motile sperm number of the
treatment group increased significantly at 10 min
compared to the control group, all these parameters
decreased markedly at 60 and 120 min in comparison
with 10 min in both the control and the treatment
groups. The difference between our results and those of

previous studies (33-35) might be due to the different
materials used and/or the style of OT administration. The
increase in the semen volume, mass activity, sperm
concentration, total sperm number, and total motile
sperm number of the treatment group at 10 min may be
explained by the acceleration of the sperm movement by
OT, which stimulates the smooth muscle cells, during its
transport from ductuli efferentes and epididymis (2),
which has OT receptors (3,4). The reduction in the semen
volume, mass activity, sperm concentration, total sperm
number, and total motile sperm number at 60 and 120
min compared to 10 min in both the control and
treatment groups is probably due to the frequency of
semen collections coupled with the decline of circulating
OT over the duration of the experiments.
In conclusion, a single dose IV administration of OT
enhances seminal plasma T, and semen volume, mass
activity, sperm concentration, total sperm number, and
total motile sperm number in the first ejaculate (10 min)
by hastening the sperm transport from the epididymis.
Additionally, it is likely that the collection of semen from
rams at short intervals causes more decreases in sperm
parameters at 60 and 120 min.
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